Newsroom
June 30, 2021
Small subsets of high-risk patients produce few or no antibodies, however. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (June 30, 2021) — In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact […]
June 28, 2021
Our biochemistry team learns more about how the coronavirus disguises itself in the body.
June 17, 2021
Dr. Jason Bowling, Infectious Diseases, and Dr. Ruth Berggren, Infectious Diseases/Center for Medical Humanities and Ethics, spoke to the San Antonio Express-News about the Delta coronavirus variant being a threat to the unvaccinated, partially vaccinated San Antonians (subscription needed). Read the story.
June 17, 2021
(Editor’s note: This story, originally posted on Feb. 11, 2021, has been updated to include the study’s publication in JAMA Oncology on June 17, 2021.) Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 17, 2021) — Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. […]
June 17, 2021
UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.
June 17, 2021
In this video, Dr. Owais Durrani, Emergency Medicine resident physician, discusses the threat of the COVID-19 delta variant in Yahoo! Finance. Watch here.